|
PBX1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.56059999999658E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.365200E-04 |
| Normal-vs-Stage2 |
1.296200E-03 |
| Normal-vs-Stage3 |
7.80450000000821E-05 |
| Normal-vs-Stage4 |
1.184160E-04 |
| Stage1-vs-Stage2 |
5.940600E-01 |
| Stage1-vs-Stage3 |
4.304600E-01 |
| Stage1-vs-Stage4 |
3.268600E-01 |
| Stage2-vs-Stage3 |
9.699600E-01 |
| Stage2-vs-Stage4 |
7.376000E-01 |
| Stage3-vs-Stage4 |
7.177800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.61260000000252E-05 |
| Normal-vs-AfricanAmerican |
1.514600E-01 |
| Normal-vs-Asian |
4.614900E-04 |
| Caucasian-vs-AfricanAmerican |
1.984990E-01 |
| Caucasian-vs-Asian |
9.429600E-01 |
| AfricanAmerican-vs-Asian |
2.519800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.55079999997199E-06 |
| Normal-vs-Female |
2.042600E-04 |
| Male-vs-Female |
1.563040E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.821500E-04 |
| Normal-vs-Age(41-60Yrs) |
6.208300E-04 |
| Normal-vs-Age(61-80Yrs) |
1.58442999999009E-05 |
| Normal-vs-Age(81-100Yrs) |
4.184100E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.286000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.239400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.574200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.247980E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.167200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.816800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.517700E-02 |
| Classical-VS-Follicular |
2.632800E-04 |
| Classical-VS-Other |
4.123800E-01 |
| Classical-VS-Normal |
2.783400E-03 |
| Tall-VS-Follicular |
6.654200E-01 |
| Tall-VS-Other |
8.704200E-01 |
| Tall-VS-Normal |
1.447130E-04 |
| Follicular-VS-Other |
6.944600E-01 |
| Follicular-VS-Normal |
8.68739999937418E-08 |
| Other-VS-Normal |
5.129500E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.12979999999674E-05 |
| Normal-vs-N1 |
5.62149999994155E-07 |
| N0-vs-N1 |
1.288580E-01 |
|
|
